Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
34.29
-0.08 (-0.23%)
Feb 20, 2026, 4:00 PM EST - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.96 billion as of February 20, 2026. Its market cap has increased by 193.47% in one year.
Market Cap
1.96B
Enterprise Value
1.63B
1-Year Change
193.47%
Ranking
Category
Stock Price
$34.29
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.96B, an increase of 143.46%. That is a compound annual growth rate of 14.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 1.96B | 8.29% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 2.13B |
| Soleno Therapeutics | 2.11B |
| Nektar Therapeutics | 2.06B |
| Sarepta Therapeutics | 1.98B |
| Vericel | 1.93B |
| Aurinia Pharmaceuticals | 1.90B |
| Olema Pharmaceuticals | 1.89B |
| Nuvation Bio | 1.87B |